Biotech startup aims to transform cancer treatment with novel immune-based technology targeting a broad spectrum of solid tumor types...
New minimally invasive diagnostic aids in ruling out Alzheimer’s disease early, expanding access to timely and accurate neurological assessments across Europe....
Breakthrough Minimally Invasive Solution Enhances Precision in Targeted Therapy Procedures, Supporting Improved Outcomes in Prostate Cancer Treatment...
The integration enhances multimodal brain monitoring by streamlining EEG data access, visualization, and clinical decision-making in critical care environments....
As regulatory shifts accelerate, next-generation non-animal models must rapidly evolve to ensure safety, efficacy, and innovation in human drug development....
Landmark integration of in vitro organ-on-a-chip and computational modeling marks a pivotal advancement in disease simulation, drug testing, and personalized medicine....
New patent strengthens global IP portfolio for noninvasive lung cancer detection platform, expanding bioAffinity’s reach into international markets ...
Danish multicenter study confirms clinical utility of genomic test in identifying low-risk stage I–II melanoma patients, advancing precision in surgical decision-making ...
New devices designed to streamline and personalize HYQVIA® administration for patients receiving subcutaneous immune globulin therapy...
Innovative device designed to maintain sinus patency post-surgery, enhancing healing and patient comfort without the need for removal...
